Abstract:The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and hyperactivation, highlights the potential of immune renormalization as a promising strategy in disease treatment. In recent years, our primary focus has centered on γδ T cell-based immunotherapy, particularly pioneering the use of allogeneic Vδ2+ γδ T cells for treating late-stage solid tumors and tuberculosis patients. However, we recognize untapped potential and optimization opportunities to fully harness γδ T cell effector functions in immunotherapy. This review aims to thoroughly examine γδ T cell immunology and its role in diseases. Initially, we elucidate functional differences between γδ T cells and their αβ T cell counterparts. We also provide an overview of major milestones in γδ T cell research since their discovery in 1984. Furthermore, we delve into the intricate biological processes governing their origin, development, fate decisions, and T cell receptor (TCR) rearrangement within the thymus. By examining the mechanisms underlying the anti-tumor functions of distinct γδ T cell subtypes based on γδTCR structure or cytokine release, we emphasize the importance of accurate subtyping in understanding γδ T cell function. We also explore the microenvironment-dependent functions of γδ T cell subsets, particularly in infectious diseases, autoimmune conditions, hematological malignancies, and solid tumors. Finally, we propose future strategies for utilizing allogeneic γδ T cells in tumor immunotherapy. Through this comprehensive review, we aim to provide readers with a holistic understanding of the molecular fundamentals and translational research frontiers of γδ T cells, ultimately contributing to further advancements in harnessing the therapeutic potential of γδ T cells.

In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity

In Respond To Commensal Bacteria: Gamma Delta T Cells Play A Pleiotropic Role In Tumor Immunity

The Microbiota is a Potential Mediator of the Crosstalk Between Γδ T Cells and Tumors

Effect of γδT Cells in Tumor

γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells

Human Γδt-Cell Subsets and Their Involvement in Tumor Immunity.

Microbiota Modulate Tumoral Immune Surveillance in Lung Through a Γδt17 Immune Cell-Dependent Mechanism.

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy

Research Progress of γδT Cells in Tumor Immunotherapy

γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer

Human Gamma Delta T-Cell Subsets And Their Involvement In Tumor Immunity

Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

γδ T cells as critical anti-tumor immune effectors

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion

The crosstalk of intratumor bacteria and the tumor

Γδ T Cells: Origin and Fate, Subsets, Diseases and Immunotherapy.

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy

Function of γδ T cells in tumor immunology and their application to cancer therapy

Regulation of T Cells by Gut Commensal Microbiota

Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy